Curcumin
Curcumin
TL;DR
Curcumin is the main active compound in turmeric and a genuine anti-inflammatory, with the best evidence in knee osteoarthritis where it performs comparably to NSAIDs over 8-12 weeks. Plain turmeric powder is almost useless orally — absorption is the whole problem, so the formulation matters more than the dose.
Ideal For
- People with knee or hand osteoarthritis who tolerate NSAIDs poorly
- Those with elevated CRP or a chronic low-grade inflammatory picture
- People with exercise-induced muscle soreness and stiffness
- Ulcerative colitis patients seeking an adjunct, with specialist input
- Anyone wanting an anti-inflammatory with a gentler gastric profile than NSAIDs
Avoid If
- You take warfarin or another anticoagulant without clinician oversight
- You have gallstones or a bile duct obstruction
- You have active liver disease or unexplained raised liver enzymes
- You have iron-deficiency anaemia — curcumin chelates iron
- You are within two weeks of scheduled surgery
- You are pregnant, at doses above culinary amounts
Frequently Asked Questions
Overview
Curcumin is the most-studied of the curcuminoids in turmeric root, and it has an unusual reputation problem: it is simultaneously over-hyped in popular health writing and genuinely effective for a narrower set of things than the hype claims.
The pharmacology starts with a serious obstacle. Native curcumin is poorly soluble, rapidly conjugated in the gut wall and liver, and cleared quickly — oral bioavailability of unformulated curcumin is close to negligible. This makes the delivery system the single most important variable. Piperine from black pepper raises bioavailability substantially by inhibiting glucuronidation; phytosome, micellar, nanoparticle and gamma-cyclodextrin formulations achieve multiples of that. Comparing a 500 mg dose of one formulation with 500 mg of another is close to meaningless, which is a large part of why the literature looks inconsistent.
Where the evidence is strongest is knee osteoarthritis. Multiple randomised trials and several meta-analyses show pain and function improvements broadly comparable to ibuprofen or diclofenac over 8-12 weeks, with markedly fewer gastrointestinal adverse events. That is a real and clinically useful result.
Beyond that: reasonable evidence for reducing systemic inflammatory markers such as CRP and IL-6, mixed but encouraging evidence in ulcerative colitis maintenance as an adjunct to mesalamine, and preliminary evidence for depression and metabolic markers. Cancer claims, which drive much of the online interest, rest on preclinical work that has not translated into human outcome trials.
Curcumin has also become one of the more common causes of supplement-associated liver injury reported to national registries — a rare event, but concentrated in high-bioavailability formulations, which is a reminder that improving absorption changes the risk profile too.
How It Works
- Inhibits NF-kB signalling, reducing transcription of downstream inflammatory mediators including TNF-alpha, IL-1beta and IL-6.
- Suppresses COX-2 and 5-LOX activity, giving a mechanism partly overlapping with NSAIDs but without the same gastric prostaglandin cost.
- Activates Nrf2, upregulating endogenous antioxidant enzymes such as glutathione S-transferase and heme oxygenase-1.
- Modulates the gut microbiome and intestinal barrier function, which may account for effects seen despite low systemic exposure.
- Undergoes rapid intestinal and hepatic glucuronidation and sulfation — the reason piperine, which inhibits glucuronidation, raises plasma levels several-fold.
- Chelates metal ions and inhibits platelet aggregation in vitro, which underlies the bleeding-risk caution with anticoagulants.
Quick Facts
- Active compound extracted from turmeric root
- Potent anti-inflammatory and antioxidant properties
- May support joint health and cognitive function
- Poor bioavailability unless formulated with enhancers
- Extensively studied with over 3000 published papers
Benefits & Outcomes
Exercise-Induced Inflammation Reduction
Reasonable evidence for soreness reduction; bioavailability is the deciding factor.
Amyloid Plaque Prevention
Strong preclinical anti-amyloid data has not translated into convincing human outcomes.
Autoimmune Modulation
Curcumin reduces inflammatory symptoms in rheumatoid arthritis and ulcerative colitis.
Back Pain Relief
Curcumin matches low-dose NSAID effects in some musculoskeletal pain trials; back-specific data are limited.
Cytokine Balance
Curcumin lowers CRP and IL-6 in trials, but only in bioavailability-enhanced formulations.
Inflammaging Reduction
Curcumin lowers CRP and IL-6 in adults with elevated baseline inflammation.
Prostate Health
Curcumin has interesting anti-inflammatory prostate data but no clinical outcome evidence.
Brain Inflammation Reduction
Strong anti-inflammatory mechanism, limited by poor brain penetration.
Tendon Strength
Curcumin may reduce tendon pain through anti-inflammatory effects without improving structure.
Menstrual Cramp Relief
Curcumin reduced dysmenorrhea pain in small RCTs and shows strong evidence for pre-menstrual symptom relief; anti-inflammatory action aligns with the prostaglandin mechanism of cramping.
mTOR Regulation
Curcumin modulates mTOR and NF-kB signaling with solid anti-inflammatory human evidence, though mTOR-specific human outcomes have not been measured.
Pain Relief
Curcumin gives modest but real relief in inflammatory and osteoarthritic pain, with better GI tolerability than NSAIDs.
Platelet Aggregation Reduction
Curcumin has mild antiplatelet activity in vitro that matters mostly as a perioperative and drug-interaction caution.
Post-Exercise Soreness Reduction
Curcumin modestly reduces soreness and speeds strength recovery after damaging exercise.
Tumor Response Rate
Curcumin has preclinical anticancer signals and no demonstrated effect on tumour response.
Antioxidant Protection
Good mechanistic support; form selection (with piperine or liposomal) is make-or-break.
Joint Comfort
Bioavailable curcumin reduces knee osteoarthritis pain with efficacy approaching NSAIDs in several head-to-head trials and better GI tolerability.
Health Concerns Addressed
Chronic Pain
NSAID-comparable in knee osteoarthritis trials; much weaker beyond it. A reasonable adjunct, never the whole strategy.
Ulcerative Colitis
Worth discussing as an add-on to mesalazine in mild to moderate disease. Evidence is add-on only — it has never been tested as monotherapy against standard care.
Inflammatory Bowel Disease
Curcumin added to mesalazine roughly tripled clinical remission rates in mild-to-moderate ulcerative colitis in randomised trials.
Neck Pain & Stiffness
Curcumin has real trial evidence for joint pain — but from knee osteoarthritis studies, not neck pain, where no direct trials exist. It is a reasonable adjunct for chronic neck discomfort, while movement, heat, and posture correction remain the proven interventions.
Bursitis
Plausible adjunct extrapolated from arthritis data; no direct bursitis trials. Fix the mechanical trigger first.
Traumatic Brain Injury
Insufficient evidence. Preclinical anti-inflammatory findings with no human TBI data and a major bioavailability barrier.
TMJ Disorder
Small trials suggest analgesia comparable to non-steroidal anti-inflammatories for jaw pain, with limited sample sizes.
Plantar Fasciitis
Curcumin has solid general anti-inflammatory evidence and may ease plantar fasciitis discomfort as an adjunct — but this condition is overload-and-degeneration more than inflammation, which is why stretching and progressive loading outperform anything swallowed.
Ankylosing Spondylitis
Mechanistically sensible and probably safe, but the spondylitis-specific trial base is nearly empty; do not let it displace treatment that preserves spinal mobility.
Herniated Disc
Curcumin may modestly ease the inflammatory component of radicular pain as an adjunct during the acute phase. Evidence comes mainly from general back pain and osteoarthritis trials, not herniated disc specifically — and it does not influence the disc's reabsorption or the need for activity-based treatment.
Shoulder Pain
A reasonable NSAID-sparing option for pain relief while you do the loading programme, particularly where the shoulder is arthritic rather than tendinopathic.
Chronic Kidney Disease
Not established. Discuss with your kidney team before use — supplement safety assumptions do not transfer to reduced clearance.
Cancer
A preclinical story that has not translated; disclose it to your oncology team.
Chronic Inflammation
Curcumin reliably lowers CRP and IL-6 in people who start with them raised. Whether that translates into better long-term outcomes is untested, so treat it as a marker-moving intervention rather than a proven disease preventer.
Knee Pain
A reasonable option for knee osteoarthritis pain if NSAIDs are unsuitable. Use a bioavailability-enhanced formulation and treat it as symptom relief.
Rheumatoid Arthritis
A reasonable adjunct for symptom relief if tolerated. The trials are too small to support it as anything more.
Chronic Back Pain
Curcumin shows modest analgesic effect in musculoskeletal pain trials, mostly in knee osteoarthritis, with little data specific to chronic back pain.
Joint Pain
One of the best-supported supplements for any indication. Over 8-12 weeks, bioavailable curcumin has matched ibuprofen and diclofenac for knee osteoarthritis pain in head-to-head trials, with far fewer gastrointestinal problems. The formulation is what decides whether it works.
Chronic Muscle Soreness
Reasonable evidence that curcumin reduces delayed-onset muscle soreness and speeds recovery of strength after hard training. The effect is modest and clearest in the 24-72 hour window after unaccustomed eccentric work.
Endometriosis
Consistent anti-inflammatory activity in endometriosis models and small human pilot work, but no adequately powered trial has shown reduced pain or lesion burden.
Supporting Research42 studies
Curcumin: A Review of Its Effects on Human Health
Hewlings SJ, Kalman DS
Review of curcumin trials reports anti-inflammatory and antioxidant effects with signals of benefit in osteoarthritis, metabolic syndrome, hyperlipidaemia, anxiety and exercise-induced muscle soreness. Native curcumin has very poor oral bioavailability; piperine or lipid/phytosome formulations raise absorption substantially.
Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study
Lopresti AL, Hood SD, Drummond PD
Curcumin and placebo were comparable through week 4, after which curcumin produced significantly greater improvement in mood, particularly in atypical depression
Memory and Brain Amyloid and Tau Effects of a Bioavailable Form of Curcumin in Non-Demented Adults: A Double-Blind, Placebo-Controlled 18-Month Trial
Small GW, Siddarth P, Li Z
Curcumin improved verbal and visual memory and attention and was associated with lower amyloid and tau PET signal in the amygdala and hypothalamus
Curcumin and inflammation: a systematic review
Hewlings, S.J., Kalman, D.S.
Curcumin potently inhibits NF-κB activation and inflammatory cytokine production Reduces pro-inflammatory markers (TNF-α, IL-1β, IL-6, IL-8) in multiple studies Antioxidant effects complement anti-inflammatory actions Effective across various inflammatory conditions (arthritis, metabolic syndrome, IBD) Dose-response relationship observed: higher doses (1000-2000mg) more effective Bioavailability is major limitation - enhanced formulations needed Safety profile excellent with minimal adverse effe
Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
Daily JW, Yang M, Park S
Turmeric extracts around 1000 mg/day of curcumin significantly reduced pain and improved function versus placebo, with effects comparable to NSAIDs.
Antioxidant and anti-inflammatory effects of curcumin/turmeric supplementation in adults: A GRADE-assessed systematic review and dose-response meta-analysis
Turmeric/curcumin supplementation might be used as a viable intervention for improving inflammatory/oxidative status.
Efficacy and safety of curcumin therapy for knee osteoarthritis: a Bayesian network meta-analysis
Zhao J, Liang G, Zhou G +2 more
To evaluate the efficacy and safety of curcumin, both alone and in combination with other drugs, in KOA treatment through a Bayesian network meta-analysis (NMA).
The efficacy of high- and low-dose curcumin in knee osteoarthritis: a systematic review and meta-analysis
Hsiao AF, et al.
The results of our meta-analysis suggest that low- and high-dose curcuminoids have similar pain relief effects and AEs in knee OA.
Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: A randomized controlled trial and an updated meta-analysis
Panahi Y, Hosseini MS, Khalili N
Curcuminoid therapy significantly reduced circulating concentrations of C-reactive protein.
Evaluation of curcumin intake in reducing exercise-induced muscle damage in athletes: a systematic review
Daniel Vasile PR, et al
Curcumin demonstrates a significant potential to relieve muscle-related symptoms, especially delayed-onset muscle soreness (DOMS) that arises from eccentric exercises.
Effect of a herbal extract containing curcumin and piperine on midazolam, flurbiprofen and paracetamol (acetaminophen) pharmacokinetics in healthy volunteers
Volak LP, Hanley MJ, Masse G +1 more
Compared with placebo, the curcuminoid/piperine preparation had no clinically important effect on midazolam or flurbiprofen pharmacokinetics.
The effect of curcumin supplementation on delayed-onset muscle soreness, inflammation, muscle strength, and joint flexibility: A systematic review and dose-response meta-analysis of randomized controlled trials
Curcumin supplementation improved range of motion and reduced muscle soreness and creatine kinase after damaging exercise.
Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance
Sharma RA, Euden SA, Platton SL +1 more
Its efficacy appears to be related to induction of glutathione S-transferase enzymes, inhibition of prostaglandin E(2) (PGE(2)) production, or suppression of oxidative DNA adduct (M(1)G) formation.
Curcumin supplementation and oxidative stress: a systematic review and meta-analysis of randomized controlled trials
Sahebkar A, Serban MC, Ursoniu S +1 more
Curcumin increased antioxidant enzyme activity and reduced circulating lipid peroxides
Effects of curcumin supplementation on delayed onset muscle soreness: a systematic review and meta-analysis
Fang W, Nasir Y
Curcumin reduced muscle soreness and creatine kinase levels versus placebo.
The efficacy and acceptability of curcumin for the treatment of depression or depressive symptoms: A systematic review and meta-analysis
Wang Z, et al
The evidence quality is low, indicating that there is great uncertainty about the efficacy and acceptability of curcumin for the treatment of depression or depressive symptoms.
Curcumin supplementation alleviates hepatic fat content associated with modulation of gut microbiota-dependent bile acid metabolism
Curcumin reduced hepatic fat content and altered gut microbiota-dependent bile acid metabolism.
Co-analgesic therapy for arthroscopic supraspinatus tendon repair pain using a dietary supplement containing Boswellia serrata and Curcuma longa: a prospective randomized placebo-controlled study
Merolla G
The dietary supplement containing Boswellia serrata and Curcuma longa alleviated short and partially mid-term pain after supraspinatus tendon repair.
Impact of Supplementation with Curcuminoids on Systemic Inflammation in Patients with Knee Osteoarthritis: Findings from a Randomized Double-Blind Placebo-Controlled Trial
Rahimnia AR, et al
Significant improvement in clinical symptoms of OA in curcuminoid-treated subjects cannot be attributed to the systemic anti-inflammatory effects of these phytochemicals.
Curcumin and cognition: a randomised, placebo-controlled, double-blind study of community-dwelling older adults
Curcumin produced small acute and chronic improvements in working memory and mood in healthy older adults.
Clinical usefulness of oral supplementation with alpha-lipoic acid, curcumin phytosome, and B-group vitamins in patients with carpal tunnel syndrome undergoing surgical treatment
Pajardi G, Bortot P, Ponti V
Curcumin phytosome within a combination regimen improved post-surgical carpal tunnel recovery scores.
Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study
Kuptniratsaikul V, Dajpratham P, Taechaarpornkul W +6 more
Curcuma domestica extract was non-inferior to ibuprofen for pain, stiffness and function, with fewer abdominal adverse events.
Nutritional Interventions in Adult Patients With Irritable Bowel Syndrome: An Umbrella Review of Systematic Reviews and Meta-analyses of Randomized Clinical Trials
Zeraattalab-Motlagh S, Ranjbar M, Mohammadi H +1 more
soluble fiber, peppermint oil, and aloe vera improved IBS symptoms, and vitamin D3 and curcumin improved IBS symptom severity
Dietary supplements for treating osteoarthritis: a systematic review and meta-analysis
Liu X, Machado GC, Eyles JP +2 more
Of 20 supplements investigated in 69 eligible studies, 7 (collagen hydrolysate, passion fruit peel extract, Curcuma longa extract, Boswellia serrata extract, curcumin, pycnogenol and L-carnitine) demonstrated large (effect size >0.80) and clinically important effects for pain reduction at short term.
Curcumin supplementation likely attenuates delayed onset muscle soreness (DOMS)
Nicol LM, et al
Oral curcumin likely reduces pain associated with DOMS with some evidence for enhanced recovery of muscle performance.
Effects of different natural products in patients with non-alcoholic fatty liver disease - A network meta-analysis of randomized controlled trials
Liu H, Li Y, Jin Y +1 more
The results of the network meta-analysis showed that artichoke leaf extract confers a relative advantage in reducing the aspartate aminotransferase (AST) levels (SUCRA: 99.1%), alanine aminotransferase (ALT) levels (SUCRA: 88.2%)
Oral supplementation of turmeric decreases proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis: a randomized and placebo-controlled study
Khajehdehi P, et al
Short-term turmeric supplementation can decrease proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis.
Therapeutic effects of turmeric or curcumin extract on pain and function for individuals with knee osteoarthritis: a systematic review
Paultre K, Cade W, Hernandez D +3 more
Most trials reported significant improvement in knee osteoarthritis pain and function with turmeric/curcumin versus placebo.
Curcumin modulates macrophage polarization and inflammatory response: a systematic review of human trials
Gorabi AM, Razi B, Aslani S +2 more
Curcumin significantly lowered circulating TNF-alpha, IL-6 and CRP
Curcumin and proton pump inhibitors for functional dyspepsia: a randomised, double blind controlled trial
Kongkam P, Khongkha W, Lopimpisuth C +1 more
Significant improvements were
Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study
Haroyan A, Mukuchyan V, Mkrtchyan N +5 more
Curcumin and its combination with boswellic acid improved osteoarthritis symptoms versus placebo.
Curcuminoids and Boswellia serrata extracts combination decreases tendinopathy symptoms
Henrotin Y, et al.
The combination of C. longa and B. serrata extracts improves symptoms in patients suffering of tendinopathy and shows a good safety. Although its effect will have to be confirmed in randomized controlled trials.
Effects of curcumin supplementation on sport and physical exercise: a systematic review
Suhett LG, de Miranda Monteiro Santos R, Silveira BKS +4 more
Curcumin reduced markers of inflammation, oxidative stress and muscle damage and lessened delayed-onset muscle soreness.
Clinical Use of Curcumin in Depression: A Meta-Analysis
Ng QX, Koh SSH, Chan HW +1 more
Curcumin significantly reduced depression severity versus placebo, with a smaller reduction in anxiety symptoms.
Investigation of the anti-inflammatory effect of Curcuma longa in Helicobacter pylori-infected patients.
Koosirirat C, Linpisarn S, Changsom D +1 more
The eradication rate of H. pylori in patients that received OAM treatment was significantly higher than the patients that received curcumin (78.9% versus 5.9%).
Safety and Efficacy of an Add-On Therapy with Curcumin Phytosome and Piperine and/or Lipoic Acid in Subjects with a Diagnosis of Peripheral Neuropathy Treated with Dexibuprofen
Di Pierro F, Settembre R
Safety and efficacy of an add-on therapy with curcumin phytosome and piperine and/or lipoic acid in subjects with a diagnosis of peripheral neuropathy treated with dexibuprofen.
The Essential Medicinal Chemistry of Curcumin
Nelson KM, Dahlin JL, Bisson J +3 more
Curcumin is chemically unstable, poorly absorbed and behaves as a pan-assay interference compound in many in vitro screens.
Effect of Curcumin on Serum Urate in Asymptomatic Hyperuricemia: A Randomized Placebo-Controlled Trial
Not fully verified
Hyperuricemia leads to gout and renal complications and may increase cardiovascular risk. Curcumin inhibits xanthine oxidase and increases uricosuric activity and, as a result, decreases serum urate (SU).
Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study
Ringman JM, Frautschy SA, Teng E +16 more
No differences were found between curcumin and placebo on cognitive or biomarker outcomes; plasma curcumin levels were very low.
Curcumin: A Review of Its' Effects on Human Health
Hewlings SJ, Kalman DS
Curcumin and inflammation: systematic review of anti-inflammatory effects in human health.
Curcumin as an adjunct in cancer therapy: systematic review of clinical trials
Mansouri K, Rasoulpoor S, Daneshkhah A +5 more
Curcumin adjuncts were associated with improved treatment tolerance and some improvement in response markers
Anti-inflammatory Properties of Curcumin: A Review of the Evidence
Menon VP, Sudheer AR
Review of the anti-inflammatory properties of curcumin.
Safety Information
Potential Side Effects
Usually mild: nausea, diarrhoea, reflux and yellow stool, more common at gram-level doses. The notable rare event is hepatotoxicity — curcumin has become one of the more frequently implicated botanicals in drug-induced liver injury registries, with cases clustered in high-bioavailability formulations and sometimes linked to an HLA-B*35:01 genotype. Stop and seek review for dark urine, jaundice or persistent right-upper-quadrant pain.
Contraindications
Avoid with gallstones or biliary obstruction, since curcumin stimulates gallbladder contraction. Avoid in active liver disease. Discontinue at least two weeks before surgery because of antiplatelet activity. Medicinal doses are not recommended in pregnancy.
Drug Interactions
- Warfarin and direct oral anticoagulants — additive antiplatelet effect; bleeding risk. Requires clinician oversight.
- Antiplatelet agents including aspirin and clopidogrel — same additive bleeding concern.
- Piperine-containing products inhibit CYP3A4 and P-glycoprotein, raising levels of many drugs including statins, calcium channel blockers and some immunosuppressants.
- Antidiabetic medication — curcumin may modestly lower blood glucose; watch for hypoglycaemia in combination.
- Tacrolimus and other narrow-therapeutic-index drugs — avoid concurrent piperine formulations entirely.
- Iron supplements — curcumin chelates iron and can reduce absorption; separate them.
Pregnancy & Breastfeeding
Pregnancy: likely_safe
Breastfeeding: likely_safe
Dosage Guidelines
Dosage Used in Studies
500-1000 mg
Best Time to Take
With meals
Best Form
With piperine or phospholipid complex
Bioavailability
Poor natural bioavailability (~1%). Piperine (black pepper extract) increases absorption by 2000%. Phospholipid formulations also improve absorption.
Dosing by Goal
| Goal | Dose | Notes |
|---|---|---|
| Knee osteoarthritis | 500-1000 mg standardised curcuminoids daily, in divided doses | Use a bioavailability-enhanced formulation. Allow 8-12 weeks; most trials showed separation from placebo by week four. |
| Systemic inflammation (raised CRP) | 500-1000 mg daily with piperine | Meta-analyses show CRP and IL-6 reductions at this range over 8-12 weeks. |
| Ulcerative colitis (adjunct) | 1-3 g daily alongside mesalamine | Adjunctive only, and under gastroenterology supervision — not a replacement for maintenance therapy. |
| High-bioavailability formulations | As low as 40-200 mg daily | Micellar and phytosome products deliver far more curcumin per milligram. Follow the product label rather than the generic gram-level figures. |
| Practical ceiling | Around 8 g curcuminoids daily | Doses to 8 g have been tolerated in trials, but GI upset is common well below that and there is no benefit signal at the top end. |
Forms Compared
Curcumin + piperine
Best for General use, budget
The classic pairing. Piperine raises bioavailability substantially, but it also inhibits CYP3A4 and can raise levels of other drugs.
Phytosome (Meriva)
Best for Osteoarthritis
Phospholipid complex with roughly 29-fold higher absorption. The form used in several of the positive joint-pain trials.
Micellar / liquid (NovaSOL)
Best for Highest absorption
Very high bioavailability, reported at over 100-fold. Effective doses are correspondingly much smaller.
Gamma-cyclodextrin (Cavacurmin)
Best for Piperine-free option
Good absorption without piperine, which matters if you take medication metabolised by CYP3A4.
Turmeric powder (culinary)
Best for Cooking
Only about 3% curcuminoids and negligible oral absorption. Excellent in food, not a therapeutic dose.
Food & Timing
Take with a meal containing fat — curcumin is lipophilic and absorption improves markedly. Splitting the daily amount into two doses maintains steadier plasma levels given the short half-life. If you use a piperine-containing product, keep it at least two hours away from medications with a narrow therapeutic index.
Medical Disclaimer
The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.
Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.